Park Ha Biological Technology Co., Ltd. BYAH
2.26 USD +0.34 (+17.84%)
At closeNov 4, 2026, 5:49 PM EST
2.24 -0.02 -0.85%
After hours · Nov 4, 5:49 PM ET
2.05 Day range 2.26
1.90 52-week range 129.60
- YTD
- -96.45%
- 1 year
- -98.23%
Financial health
Altman Z-Score
-6.52 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 4
Valuation
P/E -0.5×
FY 2021 5y median 14.7× FY 2025
P/S 4.4×
FY 2021 5y median 5.3× FY 2025
P/B 2.8×
FY 2021 5y median 8.3× FY 2025
P/FCF -3714×
FY 2021 5y median 8.8× FY 2025
EV/EBITDA -0.3×
FY 2021 5y median 9.6× FY 2025
EV/Sales 2.9×
FY 2021 5y median 5.1× FY 2025
FCF Yield -0.0%
FY 2021 5y median 0.8% FY 2025
Profitability
Gross Margin 94.4%
FY 2021 5y median 87.4% FY 2025
Operating Margin -956.5%
FY 2021 5y median 10.3% FY 2025
Net Margin -965.0%
FY 2021 5y median 10.0% FY 2025
ROE -609.9%
FY 2021 5y median 83.9% FY 2025
ROIC -578.4%
FY 2021 5y median 81.5% FY 2025
ROA -409.3%
FY 2021 5y median 7.6% FY 2025
Growth (YoY)
Revenue 6.0%
FY 2021 FY 2025
Operating Income -3142.5%
FY 2021 FY 2025
EPS (diluted) -4622.4%
FY 2021 FY 2025
Free Cash Flow -100.3%
FY 2021 FY 2025
Financial Health
Current Ratio 2.9×
FY 2021 5y median 1.8× FY 2025
Quick Ratio 2.9×
FY 2021 5y median 1.7× FY 2025
Debt / Equity 0.0×
FY 2021 5y median 0.0× FY 2025
Net Debt / EBITDA 0.2×
FY 2021 5y median -0.6× FY 2025
Interest Coverage -588998×
FY 2021 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2021 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2021 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-10-31